Cargando…

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

BACKGROUND: Pancreatic cancer has an extremely poor prognosis and prolonged survival is achieved only by resection with macroscopic tumor clearance. There is a strong rationale for a neoadjuvant approach, since a relevant percentage of pancreatic cancer patients present with non-metastatic but local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillen, Sonja, Schuster, Tibor, Meyer zum Büschenfelde, Christian, Friess, Helmut, Kleeff, Jörg
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857873/ https://www.ncbi.nlm.nih.gov/pubmed/20422030 http://dx.doi.org/10.1371/journal.pmed.1000267

Ejemplares similares

Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
por: Assfalg, Volker, et al.
Publicado: (2011)

Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
por: Nitsche, Ulrich, et al.
Publicado: (2016)

The evidence based dilemma of intraperitoneal drainage for pancreatic resection – a systematic review and meta-analysis
por: Nitsche, Ulrich, et al.
Publicado: (2014)

Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience
por: Michalski, Christoph W., et al.
Publicado: (2015)

The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990)

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)
por: Faehling, Martin, et al.
Publicado: (2022)

Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis
por: Damm, Marko, et al.
Publicado: (2021)

Future directions of neoadjuvant therapy in pancreatic cancer
por: Mota Reyes, Carmen, et al.
Publicado: (2020)

BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion
por: Kayed, Hany, et al.
Publicado: (2007)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour
por: Teich, Niels, et al.
Publicado: (2005)

Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
por: Kleeff, Jörg, et al.
Publicado: (2019)

Wound Edge Protectors in Open Abdominal Surgery to Reduce Surgical Site Infections: A Systematic Review and Meta-Analysis
por: Mihaljevic, André L., et al.
Publicado: (2015)

Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
por: Ren, Lei, et al.
Publicado: (2020)

Standard abdominal wound edge protection with surgical dressings vs coverage with a sterile circular polyethylene drape for prevention of surgical site infections (BaFO): study protocol for a randomized controlled trial
por: Mihaljevic, André L, et al.
Publicado: (2012)

Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: Case report and literature review
por: Bachmann, Jeannine, et al.
Publicado: (2005)

Surgery for Cystic Pancreatic Lesions in the Post-Sendai Era: A Single Institution Experience
por: Kleeff, Jörg, et al.
Publicado: (2015)

Case of needle tract seeding during preoperative neoadjuvant chemotherapy for resectable pancreatic cancer
por: Yane, Kei, et al.
Publicado: (2022)

Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
por: El Fitori, Jamael, et al.
Publicado: (2005)

B7-H3 and Its Role in Antitumor Immunity
por: Loos, Martin, et al.
Publicado: (2010)

How fibrosis influences imaging and surgical decisions in pancreatic cancer
por: Erkan, Mert, et al.
Publicado: (2012)

Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
por: Bernhard, H., et al.
Publicado: (1995)

Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer
por: Abiatari, Ivane, et al.
Publicado: (2010)

Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery
por: Tsuboi, Tomofumi, et al.
Publicado: (2016)

Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (PREVADER): Clinical Feasibility Trial
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2021)

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
por: Loos, Martin, et al.
Publicado: (2009)

Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis
por: Michalski, Christoph W, et al.
Publicado: (2007)

Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center
por: Michalski, Christoph W., et al.
Publicado: (2007)

Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer
por: Kong, Bo, et al.
Publicado: (2015)

Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype
por: De Oliveira, Tiago, et al.
Publicado: (2012)

Lymph Node Yield in Gastrointestinal Cancer Surgery With or Without Prior Neoadjuvant Therapy: Protocol for a Systematic Review and Meta-analysis
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2022)

Surgery With Arterial Resection for Hilar Cholangiocarcinoma: Protocol for a Systematic Review and Meta-analysis
por: Rebelo, Artur, et al.
Publicado: (2021)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
por: Michalski, Christoph W., et al.
Publicado: (2008)

Meta‐analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma
por: Schorn, S., et al.
Publicado: (2018)

Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer
por: Lambert, Aurélien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmu7lntna9e0su5a0rsulnbjkb